Sampo plc’s share buybacks 17/01/2022
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
SAMPO PLC STOCK EXCHANGE RELEASE 18/01/2022 at 08:30 am
Sampo plc’s share buybacks 17/01/2022
On 17/01/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:
Sampo plc’s share buybacks | Aggregated daily volume (in number of shares) | Daily weighted average price of the purchased shares* | Market (MIC Code) |
17,235 | 44.65 | AQEU | |
28,421 | 44.62 | CEUX | |
2,932 | 44.59 | TQEX | |
104,813 | 44.63 | XHEL | |
TOTAL | 153,401 | 44.63 |
*rounded to two decimals
On 1 October 2021, Sampo announced a share buyback programme of up to a maximum of EUR 750 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 4 October 2021, is based on the authorization granted by Sampo's Annual General Meeting on 19 May 2021.
After the disclosed transactions, the company owns in total 9,929,410 Sampo A shares representing 1.79 per cent of the total number of shares in Sampo plc.
Details of each transaction are included as an appendix of this announcement.
On behalf of Sampo plc,
Exane BNP Paribas
For further information, please contact:
Sami Taipalus
Head of Investor Relations
tel. +358 10 516 0030
Distribution:
Nasdaq Helsinki
London Stock Exchange
The principal media
Financial Supervisory Authority
www.sampo.com
Attachment

Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aadi Bioscience Announces Exploratory Biomarker Data from Patients in Its AMPECT Trial and Expanded Access Program to be Presented at 2022 ASCO Annual Meeting
- Aulos Bioscience Presents Poster on Phase 1/2 Clinical Trial of Computationally Designed IL-2 Antibody AU-007 at 2022 ASCO Annual Meeting
- Arbutus Announces Abstract Selected for Publication at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!